POPULARITY
23 episodes with primary care health sciences
3 episodes with primary care health sciences
2 episodes with primary care health sciences
2 episodes with primary care health sciences
16 episodes with primary care health sciences
2 episodes with primary care health sciences
2 episodes with primary care health sciences
2 episodes with primary care health sciences
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Monserrat Conde from the University of Oxford. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Monserrat Conde from the Nuffield Department of Primary Care Health Sciences, University of Oxford. In the March podcast Monserrat Conde discusses the findings of the recent systematic review of electronic cigarettes and subsequent smoking in young people and an evidence and gap map. The systematic review aims to assess the evidence for a relationship between the use of e-cigarettes /vapes and subsequent smoking in young people under 30, and whether this differs by demographic characteristics. There is very low certainty evidence suggesting that e-cigarette use and availability are inversely associated with smoking in young people (i.e. as e-cigarettes become more available and/or are used more widely, youth smoking rates go down or, conversely, as e-cigarettes are restricted, youth smoking rates go up). At an individual level, people who vape appear to be more likely to go on to smoke than people who do not vape; however, it is unclear if these behaviours are causally linked. Monserrat discusses the differences in the information coming from the population studies compared to the individual level studies and notes that most studies are from high income countries, in particular from the US. To see the full review: https://doi.org/10.1111/add.16773 This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Our literature searches for the EC for smoking cessation review carried out on 1st March 2025 found 1 new study (DOI: 10.1016/j.drugalcdep.2024.112271), one new ongoing study (ACTRN12625000179437) and two records linked to studies included in the review. Our literature searches for the interventions for quitting vaping review carried out on 1st March 2025 found 2 new ongoing studies (NCT06832098, ACTRN12625000143426) and four records linked to studies included in the review. For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub9/full For more information on the full Cochrane review of Interventions for quitting vaping published in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub2/full This podcast is supported by Cancer Research UK.
In this episode, we talk again with Jen MacLellan, a qualitative researcher based within the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Title of paper: Unpacking complexity: GP perspectives on addressing the contribution of trauma to women's ill healthAvailable at: https://doi.org/10.3399/BJGP.2024.0024Significant challenges and uncertainties reside in how best to manage the link between mind and body in communication with patients and in healthcare pathways. Lack of supportive resources to deliver holistic, trauma informed care risks practitioners (inadvertently) avoiding discussion of the contribution of distress in the illness presentation. A trauma informed systems level approach would support integration of psychological support within multiple care pathways and support wellbeing of practitioners providing care.This study was funded by the National Institute for Health and Care Research (NIHR) Policy Research Programme (NIHR202450). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
In this episode, we talk to Laiba Hussain, a THIS Institute Research Fellow and PhD Candidate at the Nuffield Department of Primary Care Health Sciences at the University of Oxford.Title of paper: Developing user personas to capture intersecting dimensions of disadvantage in marginalised older patients: a qualitative studyAvailable at: https://doi.org/10.3399/BJGP.2023.0412Equity is an important core value in primary care, but meeting the needs of patients who are multiply disadvantaged is increasingly difficult as services become more digitised. User personas (fictional cases based on empirical data which draw together and illustrate the multiple intersecting elements of disadvantage) could help practices better plan for the needs of disadvantaged groups.
Recording of Pharmacy Show 2023 careers session: Diversity and inclusion in pharmacy: Overcoming hurdles Dr Mahendra G Patel OBE, Head of the Centre for Research Equity , Department of Primary Care Health Sciences, University of Oxford
Dr Elisa Becker, Researcher in the Nuffield Department of Primary Care Health Sciences, discusses the role of disgust in protecting our health through the behavioural immune system, our relationship with eating meat and whether food packaging on animal products should go down the same path as cigarettes.Time Stamps: 00:00 - 02:56 - Introduction to guest, the topic and background 04:43 - 08:30 - What is the behavioural immune system? 08:31 - 14:01 - How does the behavioural immune system interact with food? 14:02 - 20:42 - Distaste or Disgust: What is the difference? 20:43 - 28:26 - Is disgust something you are born with, or do you learn it? 28:27 - 34:10 - Why is eating less meat becoming more popular? 34:11 - 36:36 - Should we be reducing our meat intake? 38:51 - 41:45 - Should meat be packaged to deter people from eating it? 41:46 - 44:18 - Outro
As the UK government proposes new plans to reduce the number of people who smoke, we talk to behaviour change researcher Nicola Lindson from the Nuffield Department of Primary Care Health Sciences to find out how the plan would work. Could we see a generation that is smoke free? Would banning flavours in e-cigarettes stop children from taking up smoking? Tune in to the latest episode of the Big Questions podcast to find out more.
In honour of World Hepatitis Day, today we focus on the Hepatitis B virus (HBV), a virus that can be transmitted through contact with infected blood and from mother to child during labour. HBV can also be transmitted sexually. It infects liver cells and causes both acute and chronic infections, which can be severe. Since HBV was discovered in 1965, we have made great progress in reducing the burden of infections and disease through prevention and antiviral treatment, but much is left to do. The World Health Organization has called for enhanced efforts along four main pathways: i) increasing awareness of HBV infection, ii) promoting prevention strategies, iii) expanding access to testing and treatment; and iv) improving surveillance, data collection and research. Today we will discuss these topics with a focus on the European Region with our three guests: - Dr. Erika Duffell, Public Health Physician, the European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden - Prof. Anna Maria Geretti, Editor in Chief, STI journal; Professor & Consultant in Infectious Diseases & Virology, Fondazione PTV, University of Rome Tor Vergata, Rome, Italy; North Middlesex University Hospital and King's College London, London, United Kingdom - Prof. Simon de Lusignan, Senior Academic General Practitioner (GP) and Director of the Royal College of GPs Research & Surveillance Centre, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom Hosted by: Dr. Fabiola Martin, Sexual Health, HIV, HTLV specialist, BMJ STI Podcast Editor, Brisbane, Australia Relevant papers: Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database https://www.journalofinfection.com/article/S0163-4453(23)00130-5/ Impact of maternal HIV–HBV coinfection on pregnancy outcomes in an underdeveloped rural area of southwest China https://sti.bmj.com/content/96/7/509 Prevalence of hepatitis B immunity and infection in home self-sampling HIV service users https://sti.bmj.com/content/98/4/286 Hepatitis A and B vaccination in gbMSM in Ireland: findings from the European MSM Internet Survey 2017 (EMIS-2017) https://sti.bmj.com/content/99/5/337 Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial https://sti.bmj.com/content/99/2/140 Hepatitis A, hepatitis B and HPV vaccine needs and coverage in MSM initiating HIV PrEP in a sexual health clinic in Paris https://sti.bmj.com/content/99/5/361
Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: AMA: Ed Mathieu, Head of Data & Research at Our World in Data, published by EdMathieu on June 17, 2023 on The Effective Altruism Forum. Hi, EAs! I'm Ed Mathieu, manager of a team of data scientists and researchers at Our World in Data (OWID), an online publication founded by Max Roser and based out of the University of Oxford. We aim to make the data and research on the world's largest problems accessible and understandable. You can learn more about our mission on our site. You're welcome to ask me anything! I'll start answering questions on Friday, 23 June. Feel free to ask anything you may want to know about our mission, work, articles, charts, or more meta-aspects like our team structure, the history of OWID, etc. Please post your questions as comments on this post. The earlier you share your questions, the higher the chances they'll reach the top! Please upvote questions you'd most like answered. I'll answer questions on Friday, 23 June. Questions posted after that are less likely to get answers. (This is an “AMA” — you can explore others here.) I joined OWID in 2020 and spent the first couple of years leading our work on the COVID-19 pandemic. Since then, my role has expanded to coordinating all the research & data work on our site. I previously worked as a data scientist at the University of Oxford in the departments of Population Health and Primary Care Health Sciences; and as a data science consultant in the private sector. For a (3.5-hour!) overview of my background, and the work of our team at OWID, you can listen to my interview with Fin Moorhouse and Luca Righetti on Hear This Idea. I also gave a talk at EA Global: London 22. Thanks for listening. To help us out with The Nonlinear Library or to learn more, please visit nonlinear.org
While the pandemic has officially declared over, the ongoing effects of a covid-19 infection are still being felt in the community. In this Deep Breath In, Jenny, Tom, and Navjoyt are joined by two leading experts on long covid. They discuss the changing profile of people being referred to specialist clinics, the way in which different strains may have different long term outcomes, and what can be done to limit the risk of developing long covid. Our guests: Trish Greenhalgh is a former GP of 30 years who is now Professor of Primary Care Health Sciences at the University of Oxford. Harsha Master is the GP lead in COVID rehabilitation at Hertfordshire Community Trust, and helped design the long covid clinical pathway there.
In this episode, we talk to Dr James Sheppard, who is an Associate Professor at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Title of paper: Predicting the risk of acute kidney injury: Derivation and validation of STRATIFY-AKIAvailable at: https://doi.org/10.3399/BJGP.2022.0389Acute kidney injury (AKI) is one of the more serious adverse events associated with antihypertensive treatment, reducing an individual's health-related quality of life and increasing the risk of admission to hospital. Clinical guidelines recommend that when prescribing antihypertensives GPs should take into account the likelihood of both the benefits and harms from treatment, but few data exist in regard to the risk of AKI. A clinical prediction model was developed and externally validated for the risk of AKI up to 10 years in the future in patients eligible for antihypertensive medication, incorporating commonly recorded patient characteristics, comorbidities, and prescribed medications. The model showed good discrimination and good calibration for probabilities up to 20%, enabling GPs to accurately identify patients at higher risk of AKI. This could be useful to reassure the majority of patients starting or continuing treatment that their risk of AKI is very low.
How is pharma tackling its climate change impact? Pharmaceuticals are estimated to contribute to up to 55% of health care's carbon footprint. As pressure increases for health systems to move towards net zero, we explore how pharmaceutical companies are playing their part to reduce their climate impact. Recently published research, led by Dr Amy Booth (medical doctor, PhD candidate at the University of Oxford), in collaboration with Dr Chris Winchester (CEO Oxford PharmaGenesis) and co-authors Professor Sara Shaw, Dr Stuart Faulkner and Dr Alexandra Jager at the Nuffield Department of Primary Care Health Sciences, University of Oxford, analysed the climate change targets of leading pharmaceutical companies, progress on reducing their emissions, and the strategies that companies are implementing to reduce their climate impact. The research showed that companies are setting climate change targets and for the most part, showing reductions in scope 1 and 2 emissions through a range of strategies. However, scope 3 emissions were inconsistently reported, and more work needs to be done to reduce them. With something as urgent as climate change, collaboration between industry, academia, governments and other stakeholders is vital to reaching targets and reducing emissions. You can read the full article at: https://www.mdpi.com/1660-4601/20/4/3206 Enjoy the episode!
In this episode, we talk to Dr Emma Ladds, who is a Primary Care In-Practice Fellow and GP based at the Nuffield Department of Primary Care Health Sciences at the University of Oxford.Title of paper: ‘How have remote care approaches impacted continuity? A mixed-studies systematic review'Available at: https://doi.org/10.3399/BJGP.2022.0398The value of continuity in primary care has been repeatedly demonstrated for multiple outcomes. However little is known about how the expansion of remote and digital care models have impacted continuity. Here we demonstrate a disturbing lack of systematic research in this area and emphasize the need for real world explorations of the links between the shift to remote care, continuity and equity to ascertain when and for whom continuity adds most value and how this can be enabled or maintained.
In this episode, we talk to Dr Sarah Tonkin-Crine, an Associate Professor and Health Psychologist based within the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Title of paper: Implementing antibiotic stewardship in high prescribing English general practices: a mixed-methods studyAvailable at: https://doi.org/10.3399/BJGP.2022.0298An intervention to support the implementation of three evidence-based antimicrobial stewardship (AMS) strategies was evaluated in nine high antibiotic prescribing general practices in England. General practice teams received intervention materials and chose to use them in substantially different ways in real-life settings, outside of trial conditions. AMS strategies are complex interventions that require sufficient understanding and engagement by clinicians for successful adoption and use, to obtain the full benefit in reducing antibiotic prescribing. This study highlights that remote, one-sided delivery of AMS strategies should be done cautiously to avoid misunderstanding and sub-optimal use.
Today, we talk to Dr Claire Taylor, a GP and NIHR Clinical Lecturer at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Paper: Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy studyAvailable at : https://doi.org/10.3399/BJGP.2022.0278International guidelines recommend natriuretic peptide (NP) testing to prioritise referral for heart failure (HF) diagnostic assessment in primary care. European Society of Cardiology (ESC) and National Institute for Health and Care Excellence (NICE) guidelines differ significantly in their recommended NP referral threshold. Our study found at the lower ESC threshold fewer HF diagnoses were missed but more referrals from primary care would be required. Healthcare systems need to balance the risk of a missed or delayed diagnosis for individual patients with capacity in diagnostic services. An NP level below both the ESC and NICE thresholds was reliable in ruling out HF.
Dr Clare J Taylor, Academic GP, explores how we can use large, anonymised GP datasets to improve our understanding of heart failure management in primary care. Nearly all UK residents are registered with a general practice and data collected during routine consultations can be used by researchers to understand more about common diseases. Heart failure occurs when the heart has been damaged and is struggling to pump enough blood to meet the needs of the body. Patients can feel breathless, exhausted and have swollen legs but treatments to improve quality of life and outlook are available. In this lecture, Dr Taylor explores how we can use large, anonymised GP datasets to improve our understanding of heart failure management in primary care. With a focus on the patient throughout, she presents her recent work on heart failure diagnosis and survival to illustrate the power, and limitations, of using big GP data for research and to ultimately improve patient care. Part of the Evidence-Based Health Care programme. About the speaker: Dr Clare J Taylor is a Clinical Lecturer in the Nuffield Department of Primary Care Health Sciences. Her research explores heart failure in primary care using big data epidemiology, prospective studies, and qualitative work. The findings have been published in high-impact journals and informed national and European heart failure policy. Clare is also experienced in postgraduate teaching and doctoral supervision and was a member of the National Institute for Health and Care Excellence Chronic Heart Failure guideline committee. She also works as an NHS general practitioner.
Dr Trish Greenhalgh explains how we miss the boat when we discount real-world evidence in favor of randomized trial evidence. This podcast is intended for US healthcare professionals only. To read a full transcript of this episode or to comment please visit: https://www.medscape.com/features/public/machine Eric J. Topol, MD, Director, Scripps Translational Science Institute; Professor of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Editor-in-Chief, Medscape Abraham Verghese, MD, Physician, author, and educator; Professor and Vice Chair, Theory & Practice of Medicine, Department of Medicine, Stanford University, Stanford, California Trish Greenhalgh, OBE, MD, Professor of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom Orthodoxy, illusio, and playing the scientific game: a Bourdieusian analysis of infection control science in the COVID-19 pandemic [version 3; peer review: 2 approved]. Wellcome Open Res 2021, 6:126 https://doi.org/10.12688/wellcomeopenres.16855.3 Ten scientific reasons in support of airborne transmission of SARS-CoV-2. The Lancet, Vol 397; May 2021 https://doi.org/10.1016/S0140-6736(21)00869-2 Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent. BMJ Evidence-Based Medicine October 2022; volume 27; number 5 http://doi.org/10.1136/bmjebm-2022-111952 Long covid—an update for primary care. BMJ 2022;378:e072117 http://doi.org/10.1136/bmj-2022-072117 You may also like: Medscape's Chief Cardiology Correspondent Dr John M. Mandrola's This Week In Cardiology https://www.medscape.com/twic Discussions on topics at the core of cardiology and the practice of medicine with Dr Robert A. Harrington and guests on The Bob Harrington Show https://www.medscape.com/author/bob-harrington For questions or feedback, please email: news@medscape.net
Are e-cigarettes effective in helping smokers to quit? It's one of the most hotly contested questions in the battle over vaping, but an answer may finally be in hand. According to the latest Cochrane Review of Electronic Cigarettes for Smoking Cessation, there is “high-certainty evidence” that nicotine vapes are more effective than traditional nicotine replacement therapies, such as nicotine patches and gum, in helping people to quit smoking. Dr. Jamie Hartmann-Boyce, associate professor at the University of Oxford's Nuffield Department of Primary Care Health Sciences and editor at Cochrane Tobacco Review Group, is joining us today to discuss the new evidence. Only on RegWatch by RegulatorWatch.com. Released: November 23, 2022 Produced by Brent Stafford https://youtu.be/U0ytawxQgWs Make RegWatch happen, go to https://support.regulatorwatch.com
In this episode, we talk to Professor Trish Greenhalgh, Professor of Primary Care Health Sciences at the University of Oxford. Paper: UK newspapers “on the warpath”: media analysis of remote consulting in 2021 Available at: https://doi.org/10.3399/BJGP.2022.0258 (https://doi.org/10.3399/BJGP.2022.0258) How this fits in In 2020, the shift from in-person to remote consulting in general practice was depicted positively by the media as part of the “war” on COVID-19. In 2021, remote consulting was depicted negatively by the media, and linked in press articles to difficulties accessing primary care and compromises in patient safety. Newspapers led campaigns which successfully put pressure on government to require a return to in-person consultations.
Dr Jamie Hartmann-Boyce is associate professor at the Nuffield Department of Primary Care Health Sciences, and her team published a paper at the start of the Covid-19 pandemic predicting how care for patients with conditions like diabetes might worsen during national emergencies like the Covid pandemic. She also had a paper in Diabetes care looking at the evidence that patients with diabetes were at increased risk of more severe Covid-19, and has also looked at whether Covid-19 infection may itself lead to a higher risk of developing diabetes. There is now some evidence starting to emerge that a significant number of patients with diabetes may have been lost to follow up during the pandemic, and others may now have poorer control, although there is some variation within different subgroups. We discussed what this might mean for the care of patients with diabetes, and other long term conditions, and how we might now start to address this problem. Listen to the end to hear whether e-cigarettes are a good thing, and what our favourite film trilogies are! The Centre for Evidence-Based medicine Oxford COVID-19 Evidence Service SNUG Members Day 2022 The Godfather theme song
In this episode we talk to Professor Trisha Greenhalgh from the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Paper: Why do GPs rarely do video consultations? A qualitative study in UK general practice https://doi.org/10.3399/BJGP.2021.0658 (https://doi.org/10.3399/BJGP.2021.0658) The pandemic provided strong impetus to extend remote consultation services in general practice, but video remains infrequently used. This study used in-depth case study methods to explore the multiple interacting influences on the non-adoption and abandonment of video consulting in general practice. Telephone was considered adequate for most remote consultations; the need for a hands-on physical examination explained why video rarely replaced in-person assessment in the remainder.
In this episode we talk to Dr Gail Hayward who is a GP and Associate Professor of Primary Care at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Paper: Urine collection devices to reduce contamination in urine samples for diagnosis of uncomplicated UTI: a single-blind randomised controlled trial in primary care https://doi.org/10.3399/BJGP.2021.0359 (https://doi.org/10.3399/BJGP.2021.0359) This trial is the first to evaluate the effectiveness of urine collection devices in the population of most relevance: women with symptoms of UTI presenting to primary care. Neither device tested reduced sample contamination when used by women presenting to primary care with symptoms attributable to uncomplicated UTI. Since there are no other studies in this population, their use cannot be recommended for this purpose in this setting.
In this episode we speak to Dr Alex Walker who is an epidemiologist at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Paper: Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY https://doi.org/10.3399/BJGP.2021.0301 (https://doi.org/10.3399/BJGP.2021.0301) Early case definitions and clinical guidelines have been published to describe long COVID, and clinical codes based on these guidelines were published in late 2020. This study found wide variation in the early use of these codes, by practice, geographic region, and practice electronic health record software. Promotion of the clinical guidance and codes is important for future research and ongoing patient care.
In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, talks to Dr Ash Clift Nuffield Department of Primary Care Health Sciences, University of Oxford. The evidence surrounding COVID-19 has been conflicting and inconsistent. This podcast discusses the findings of this observational and Mendelian randomisation study using the UK Biobank cohort. The author discusses the findings with regards to the potential causal effect of cigarette smoking on the severity of COVID-19 infection and what this means for both the public and clinicians. Related article: https://thorax.bmj.com/content/thoraxjnl/early/2021/09/12/thoraxjnl-2021-217080
In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, talks to Dr Ash Clift Nuffield Department of Primary Care Health Sciences, University of Oxford. The evidence surrounding COVID-19 has been conflicting and inconsistent. This podcast discusses the findings of this observational and Mendelian randomisation study using the UK Biobank cohort. The author discusses the findings with regards to the potential causal effect of cigarette smoking on the severity of COVID-19 infection and what this means for both the public and clinicians. Related article: https://thorax.bmj.com/content/thoraxjnl/early/2021/09/12/thoraxjnl-2021-217080
The Federal Drugs Administration has withdrawn nearly a million e-cigarettes from the US market. Does this signal a turning point for the vaping industry? Small manufacturers like Amanda Wheeler, owner of Jvapes in Arizona and president of the American Vapor Manufacturers Association, are concerned about heavier regulation, as she tells Joshua Thorpe. In the UK, Public Health England promotes vaping as a method to stop smoking, as we hear from Jamie Hartmann-Boyce, associate professor at the Nuffield Department of Primary Care Health Sciences, at the University of Oxford. But Desmond Jenson, a lawyer at the Public Health Law Center at the Mitchell Hamline School of Law in Minnesota argues that regulators need to do more to tackle a youth vaping epidemic. Producer: Frey Lindsay (Picture: a woman vaping. Credit: Getty Images.)
In this episode we talk to Dr Sharon Dixon, GP and researcher, at the Nuffield Department of Primary Care Health Sciences, University of Oxford. The research was funded by the NIHR School of Primary Care Research. Paper: Navigating possible endometriosis in primary care: a qualitative study of GP perspectives https://doi.org/10.3399/BJGP.2021.0030 (https://doi.org/10.3399/BJGP.2021.0030) There are documented time lags between women presenting to primary care with symptoms suggesting endometriosis and receiving a diagnosis. It has been suggested that increasing GPs awareness will improve this situation. As GPs perspectives on these care journeys are not known, how best to educate health professionals to reduce delays in diagnosis is unclear. Even with awareness of the possibility of endometriosis, GP accounts suggest that journeys are complex and can involve navigating significant uncertainties, including when managing women whose symptoms are well controlled with primary care treatment or who do not want to have referral or operative investigation.
In this episode we talk to Dr Julian Treadwell who is a GP and doctoral research fellow at the Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Woodstock Road, Oxford. Paper: GPs' use and understanding of the benefits and harms of treatments for long-term conditions: a qualitative interview study https://doi.org/10.3399/BJGP.2021.1027 (https://doi.org/10.3399/BJGP.2020.1027) Research has shown that doctors, including GPs, often have poor knowledge of quantitative benefits and harms of treatments, such as absolute risk reduction and numbers needed to treat. Yet this kind of information is considered key to shared decision making and optimal management of polypharmacy. This qualitative study explored the attitudes and understanding of GPs in the UK with regard to this issue, and reveals a complex set of behaviours and feelings. These findings will be of interest to doctors wishing to reflect on their own practice, and to authors of guidelines and information resources. Links https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/shared-decision-making (https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/shared-decision-making)
In this episode I speak to Dr Marta Wanat who is a Senior Qualitative Researcher at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Paper: Transformation of primary care during the COVID-19 pandemic: experiences of healthcare professionals in eight European countries https://doi.org/10.3399/BJGP.2020.1112 (https://doi.org/10.3399/BJGP.2020.1112) Previous qualitative studies exploring the experiences of healthcare professionals during the COVID- 19 pandemic have mainly focused on secondary care. This study explored the experiences of primary care healthcare professionals' (PCPs) experiences of primary care transformation during the first peak of COVID-19 pandemic in England, Belgium, the Netherlands, Ireland, Germany, Poland, Greece and Sweden. PCPs described rapidly adapting to new circumstances by making decisions in how to transform primary care delivery for both COVID-19 and non-COVID-19 patients, with limited training and resources. Flexibility and autonomy are necessary ingredients in primary care provision that should be preserved, coupled with provision of practical information on how to adapt services, ongoing training, and mental health support services for PCPs.
This episode features Laura Health (Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK). COVID-19 has a mortality of between 1% and 2% and is the deadliest pandemic in living memory. The elderly, and those with pre-existing conditions tend to be most vulnerable to severe disease and death. Common symptoms experienced at the end of life include breathlessness and agitation/delirium. Care of those dying of COVID-19 is an understudied aspect of the pandemic. This paper is the first review of international studies describing pharmacological symptom management of adult patients dying of COVID-19. Our thorough search found only seven papers that documented pharmacological symptom management of this patient cohort, highlighting the lack of research in this area. A higher proportion of patients required continuous subcutaneous infusions for medication delivery than is typically seen at the end of life. Modest doses of commonly used end of life medications were required for symptom control. There was a lack of information about how effectiveness was measured, and whether medications used effectively alleviated symptoms.
In this episode of the R&H Podcast, our featured R&H representative, Dr Rageshri Dhairyawan and invited guest, Ms Bakita Kasadha, walks us through racism's effect on treating and understanding HIV in the United Kingdom. Bakita draws from her experiences working with the Nuffield Department of Primary Care Health Sciences, WHO's Global Validation Advisory Committee, and her writings for NAM aidsmap. Together, we explore how racism suppresses the very process of health research and services designed to combat ill health; and how ultimately, pervasive issues of misrepresentation, stereotypes, and stigma stand between HIV care and those who need it. Find the audio transcription for this episode here.
We talk to Dr Claire Friedemann Smith, a senior researcher at the Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford. The paper is: GPs' use of gut feelings when assessing c ancer risk in primary care: A qualitative study Read the paper: https://doi.org/10.3399/bjgp21X714269 (https://doi.org/10.3399/bjgp21X714269) GP's gut feelings have often been criticised because of their subjective nature. GP's suggested that they did not rely on gut feelings in isolation but used them as prompts to gather additional clinical evidence to support their decisions and to reduce the potential criticism of being ‘unscientific'. They stated that gut feelings were integral to efficient and professional patient care, particularly when the presentation causing concern fell into a grey-area of clinical practice that guidelines do not adequately address. As gut feelings were described as most reliable when used by an experienced GP, grounded on years of observations and accumulated clinical knowledge, there may be a role for mentoring less experienced GPs to understand and respond appropriately to them.
In this episode we talk to Dr Gilly Mroz who is a postdoctoral researcher at the University of Oxford and Professor Trish Greenhalgh from the Nuffield Department of Primary Care Health Sciences at Oxford as well. The title of the paper is: Changing media depictions of remote consulting in COVID-19: analysis of UK newspapers Read the paper: https://doi.org/10.3399/BJGP.2020.0967 (https://doi.org/10.3399/BJGP.2020.0967) Remote consulting changed UK general practice overnight, resulting in new barriers to access and levels of care. This study explored how this change was portrayed in national newspapers over time. Early newspaper coverage of this change was largely positive and emphasised its necessity for safety reasons during the pandemic. Later coverage was more negative, raising concerns about quality and safety of care and digital inequalities.
In this episode, we talk about research that explores the perspectives of GPs and considers how we can help women and girls who are at risk or have experienced female genital mutilation (FGM). Dr Sharon Dixon is a GP and researcher at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Supporting patients with female genital mutilation in primary care: a qualitative study exploring the perspectives of GPs' working in England Read the paper: https://doi.org/10.3399/bjgp20X712637 (https://doi.org/10.3399/bjgp20X712637) There are an estimated 137,000 women and girls born in countries where FGM is traditionally practised who are permanently resident in England and Wales in 2011. Though there was a significantly higher prevalence in urban areas, it was estimated that there would be no local authority areas without any women affected by FGM. The authors are unaware of any previous work considering GPs' perspectives on supporting women with female genital mutilation (FGM) in primary care, including the impacts of recent English policy which includes a mandatory reporting policy and FGM Enhanced Dataset. GPs described tensions between their caring role and the policy requirements placed on them. The provision of specialist support, and holistic education could support GPs when caring for those from communities affected by FGM.
‘AUTISM VR’ is an open, global platform of researchers and academics that focuses on accommodating autistic people as well as parents/carers/professionals/researchers in this life journey providing awareness and information across the age span and across variations on the spectrum. We are aspiring to support an open community forum, focused on sharing information in the field, state-of-the-art research/applications, providing a glimpse of all research/projects/concepts/ideas already put into effect, encouraging all members to present their own ideas/initiatives, and finally concluding on what the best approaches are. ‘AUTISM VR’ is dedicated to providing educational events and workshops around autism. Join us to network and connect with other like-minded people supporting the autistic community. If you have any projects, knowledge, experience, insights, challenges you would be willing to share with the community, join our channel. AUTISM VR Team Anna Xygkou (PhD researcher, School of Engineering and Digital Arts, University of Kent) Krysia Waldock (PhD researcher, Tizard Centre, University of Kent) Dr. Damian Milton (Lecturer in Intellectual Disabilities, Tizard Centre, University of Kent) Dr. Nigel Newbutt (Senior Lecturer and Senior Researcher, Department of Education and Childhood, the University of the West of England) Dr. Paraskevi Triantafyllopoulou (Lecturer in Intellectual Disabilities, Tizard Centre, University of Kent) Dr. Melina Malli (Post-Doctoral Researcher, Nuffield Department of Primary Care Health Sciences, University of Oxford) New Virtual Reality Channel for/with autistic people -AUTISM with Anna Xygkou ----------------------------- Connect with Anna: Useful links to AUTISM VR: Discord: https://discord.gg/9zJ5tnH AltspaceVR channel: https://account.altvr.com/channels/autism Download AltspaceVR platform https://altvr.com/get-altspacevr/ Email address: autismteam2020@gmail.com Youtube link: AUTISM VR ------------ Want to learn more about those events and connect with the XReality community? *XReality Official Website: https://www.hummingbirdsday.com/xreality *Please fill out the survey to get the best experience in XReality community: https://bit.ly/2EfxlFe *Join our Discord: https://discord.gg/bQ6neHR *Join our Facebook Fan Page:https://www.facebook.com/XRealityMeetup (https://www.facebook.com/XRealityMeetup/) *Watch recorded speaker event video: https://www.youtube.com/dominiquewu *Join XReality Membership - sign up our newsletter: https://bit.ly/32jBqAr *Subscribe our Podcast: https://apple.co/3iMMzAM
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
In this episode you'll hear my interview with Dr. Jamie Hartmann-Boyce, senior research fellow and departmental lecturer at the Nuffield Department of Primary Care Health Sciences of University of Oxford. Dr. Hartmann-Boyce is the lead investigator of a recent article published in Diabetes Care providing an overview of potential associations between COVID-19 and diabetes. Published in June, the article proved to be a valuable resource for clinicians. We reached out to Dr. Hartmann-Boyce to learn more about the role of medical research during the COVID-19 era.
How can we express evidence in a way that means people will engage with it and understand it? How do team dynamics and individual context influence whether evidence is used appropriately and fully? What can we learn from the experience in human medicine? These questions and more are explored in this roundtable discussion featuring: Trish Greenhalgh, Professor of Primary Care Health Sciences, University of Oxford Dr Zoe Belshaw, internal medicine specialist, Centre for Evidence-Based Veterinary Medicine at the University of Nottingham/PDSA Dr Louise Buckley, RVN and Lecturer, University of Edinburgh/Royal (Dick) School of Veterinary Studies Laura Playforth, Veterinary Surgeon, Vice-Chair of RCVS Knowledge Quality Improvement Advisory Board and Professional Standards Director at Vets Now Adewole Adekola and Imogen Schofield: Veterinary Surgeons and PhD students at the Royal Veterinary College Download the transcript from the RCVS Knowledge website. The Knowledge Sessions bring together specialists from across the industry to examine the landscape, propose potential approaches to complex problems, and provide practical advice on a range of subjects.
Advice about whether the public should wear face masks, to protect against infection by the coronavirus, differs around the world. In Europe, policy recommendations are mostly geared towards homemade masks. As this country waits to find out how we’ll venture out of lock down, should we be wearing face masks out in public too? The government’s mantra throughout the pandemic has been “follow the science” but on this issue there is ongoing debate, with strongly held and differing views. The Royal Society’s DELVE Initiative (Data Evaluation and Learning for Viral Epidemics) put out a report this week to try to bring some clarity to the issue. Marnie Chesterton asks Professor of Primary Care Health Sciences at Oxford University, Trisha Greenhalgh, and microbiologist and Professor of Environmental Healthcare at the University of Southampton, William Keevil, why there is so little science to inform the policy-makers. If the government recommends that we all wear cloth masks, we'll be wearing them for the common good - they’re better at stopping the wearer from spreading the virus than protecting him or her from catching it. Choosing one that fits, made from the right material, and keeping it clean is also crucial. If you’re not really up to making your own mask, Professor Mark Miadownik at UCL’s Institute of Making warns against the single-use surgical masks, now a common addition to the litter scene and a bane to the environment. As the SARS-CoV-2 virus that causes COVID-19 continues to spread at an alarming rate in the United States, with well over a million confirmed cases and over 70,000 deaths, attention in the White House has been turning to suggestions that the virus originated in the Institute of Virology Laboratory in Wuhan, China and not in the wild where bats are the ultimate suspected source. For years, a group there led by “bat woman” Jungli Shi, have been collecting virus samples and studying them to see if they could infect us humans. This is standard virology, trying to understand where the next pandemic viral threat might come from. But conspiracy theorists have been suggesting that there’s more going on, such as deliberate genetic manipulation of the viruses, weaponising them, or just unsafe management. These ideas have been taken up by President Trump and his team. BBC Inside Science reporter Roland Pease asks the experts what they think. Is there any place for this sort of politics in the pandemic? Presenter - Marnie Chesterton Producers - Fiona Roberts and Beth Eastwood
A new podcast from The BMJ, to help GP's feel more connected, heard, and supported. Subscribe on; Apple podcasts - https://bit.ly/applepodsDBI Spotify - https://bit.ly/spotifyDBI Google podcasts - https://bit.ly/googlepodsDBI In our first episode, we discuss the highs and lows of video consultations, and how coronavirus has altered the landscape of business as usual for GPs. How will this change affect our relationships with our patients? How do we cope with frustrating technical issues? Are we more likely to miss a crucial diagnosis if we can't rely on physical examinations? And, finally, are teleconsultations the future of GP practice? Our guests: Trish Greenhalgh is a former GP of 30 years who is now Professor of Primary Care Health Sciences at the University of Oxford. Trish is a leading researcher on video consultations. Fiona Stevenson is a medical sociologist and researcher based at UCL. She is the co-director of their e-health unit. Deep Breath Out - the Rob Auton Daily Podcast https://play.acast.com/s/robautonpodcast https://www.bmj.com/podcasts/deepbreathin
A new podcast from The BMJ, to help GP's feel more connected, heard, and supported. Subscribe on; Apple podcasts - https://bit.ly/applepodsDBI Spotify - https://bit.ly/spotifyDBI Google podcasts - https://bit.ly/googlepodsDBI In our first episode, we discuss the highs and lows of video consultations, and how coronavirus has altered the landscape of business as usual for GPs. How will this change affect our relationships with our patients? How do we cope with frustrating technical issues? Are we more likely to miss a crucial diagnosis if we can't rely on physical examinations? And, finally, are teleconsultations the future of GP practice? Our guests: Trish Greenhalgh is a former GP of 30 years who is now Professor of Primary Care Health Sciences at the University of Oxford. Trish is a leading researcher on video consultations. Fiona Stevenson is a medical sociologist and researcher based at UCL. She is the co-director of their e-health unit. Deep Breath Out - the Rob Auton Daily Podcast https://play.acast.com/s/robautonpodcast https://www.bmj.com/podcasts/deepbreathin
A new podcast from The BMJ, to help GP's feel more connected, heard, and supported. Subscribe on; Apple podcasts - https://bit.ly/applepodsDBI Spotify - https://bit.ly/spotifyDBI Google podcasts - https://bit.ly/googlepodsDBI In our first episode, we discuss the highs and lows of video consultations, and how coronavirus has altered the landscape of business as usual for GPs. How will this change affect our relationships with our patients? How do we cope with frustrating technical issues? Are we more likely to miss a crucial diagnosis if we can't rely on physical examinations? And, finally, are teleconsultations the future of GP practice? Our guests: Trish Greenhalgh is a former GP of 30 years who is now Professor of Primary Care Health Sciences at the University of Oxford. Trish is a leading researcher on video consultations. Fiona Stevenson is a medical sociologist and researcher based at UCL. She is the co-director of their e-health unit. Deep Breath Out - the Rob Auton Daily Podcast https://play.acast.com/s/robautonpodcast https://www.bmj.com/podcasts/deepbreathin
Dr Jamie Hartmann-Boyce discusses a case study of systematic reviews of electronic cigarettes for smoking cessation, looking across meta-analyses in this area. Dr Jamie Hartmann-Boyce is Senior Researcher, Health Behaviours team at the Nuffield Dept of Primary Care Health Sciences.
Dr Jamie Hartmann-Boyce discusses a case study of systematic reviews of electronic cigarettes for smoking cessation, looking across meta-analyses in this area. Dr Jamie Hartmann-Boyce is Senior Researcher, Health Behaviours team at the Nuffield Dept of Primary Care Health Sciences.
A presentation given by Nerys Astbury (Nuffield Department of Primary Care Health Sciences, Oxford) at the UBVO Green Templeton College Obesity Conference, 16 September 2019
The increased reliance of health systems on the digital record as the primary mechanism for storing data on consultations and other health interactions has opened new opportunities for research, healthcare innovation, and health policy. The electronic health record (eHR) is now ubiquitous in many countries, in hospital and primary care settings, and in some countries their health systems in terms of reporting patient care activity are essentially 'paperless'. Health systems globally are also facing accelerating challenges as they seek to deliver better value healthcare against the background of increasing levels of chronic disease, ageing populations, financial pressures and demands on public spending. Digital health tools and services are held up to be part of the solution to these challenges, potentially offering low-cost and patient-centred solutions. There has been huge investment in Big Data research in health, particularly in relation to digitised imaging and automated reporting and predictive modelling using phenotypic and increasingly genetic data. There have also been similar gains in more applied research that explores the potential of accessing the huge quantum of data held in the eHR, and linkage of these data to other national or regional databases, such as mortality records or cancer data. This session will explore some of the applications for routine data research, illustrated by projects that have resulted in research success and better healthcare. This will include the exemplars of using large eHR platforms and prescribing data platforms to create infrastructure for i) common disease surveillance, such as the UK RCGP RSC; ii) generation and validation of disease risk assessment tools, such as QRisk scores; iii) pragmatic electronic follow up trials; iv) within practice systems dashboard feedback reports, eg data normalised to regional and national rates on prescribing and investigation physician activity; v) traditional epidemiological linkage studies; and vi) linkage to long term phenotypic follow up of established disease cohorts. Richard Hobbs is Nuffield Professor of Primary Care at the University of Oxford, and Head of the Nuffield Department of Primary Care Health Sciences. He has served a decade as National Director of the National Institute for Health Research's School for Primary Care Research and was Director of the NHS Quality and Outcomes Framework (QOF) Review panel from 2005-09. He has served many national and international scientific and research funding boards in UK, Ireland, Canada, and WHO, including the BHF Council, British Primary Care Cardiovascular Society, and the ESC Council for Cardiovascular Primary Care. He currently chairs the European Primary Care Cardiovascular Society, a WONCA Special Interest Group. He is one of the world's leading academics in primary care, and has developed at Oxford one of the largest and most highly ranked centres for academic primary care globally. He has also made major contributions to growing primary care academic capacity, in terms of people development and research networks. A highly cited primary care clinical scientist, he has authored over 450 peer reviewed publications, has an h-index of 90, with over 63000 citations (36000 since 2013) and 81 papers cited over 100 times, 14 papers cited over 1000 times and 7 papers with over 2000 citations. He has an outstanding track record in cardiovascular research, delivering trials that changed international guidelines and practice, especially in the areas of stroke prevention in atrial fibrillation (BAFTA, SAFE, and SMART trials), heart failure burden and diagnosis (ECHOES and REFER trials), and hypertension self-management (TASMINH series). He is only the fifth ever recipient of the RCGP Discovery Prize in 2018 (an occasional award made since 1953) and received an inaugural Distinguished Researcher Shine Prize plus Best Presentation Prize at the WONCA World Congress in 2018. He was awarded a CBE for services to medical research in the 2018 New Year's Honours. This talk was held as part of the Big Data Epidemiology course which is part of the Evidence-Based Health Care Programme.
The increased reliance of health systems on the digital record as the primary mechanism for storing data on consultations and other health interactions has opened new opportunities for research, healthcare innovation, and health policy. The electronic health record (eHR) is now ubiquitous in many countries, in hospital and primary care settings, and in some countries their health systems in terms of reporting patient care activity are essentially 'paperless'. Health systems globally are also facing accelerating challenges as they seek to deliver better value healthcare against the background of increasing levels of chronic disease, ageing populations, financial pressures and demands on public spending. Digital health tools and services are held up to be part of the solution to these challenges, potentially offering low-cost and patient-centred solutions. There has been huge investment in Big Data research in health, particularly in relation to digitised imaging and automated reporting and predictive modelling using phenotypic and increasingly genetic data. There have also been similar gains in more applied research that explores the potential of accessing the huge quantum of data held in the eHR, and linkage of these data to other national or regional databases, such as mortality records or cancer data. This session will explore some of the applications for routine data research, illustrated by projects that have resulted in research success and better healthcare. This will include the exemplars of using large eHR platforms and prescribing data platforms to create infrastructure for i) common disease surveillance, such as the UK RCGP RSC; ii) generation and validation of disease risk assessment tools, such as QRisk scores; iii) pragmatic electronic follow up trials; iv) within practice systems dashboard feedback reports, eg data normalised to regional and national rates on prescribing and investigation physician activity; v) traditional epidemiological linkage studies; and vi) linkage to long term phenotypic follow up of established disease cohorts. Richard Hobbs is Nuffield Professor of Primary Care at the University of Oxford, and Head of the Nuffield Department of Primary Care Health Sciences. He has served a decade as National Director of the National Institute for Health Research’s School for Primary Care Research and was Director of the NHS Quality and Outcomes Framework (QOF) Review panel from 2005-09. He has served many national and international scientific and research funding boards in UK, Ireland, Canada, and WHO, including the BHF Council, British Primary Care Cardiovascular Society, and the ESC Council for Cardiovascular Primary Care. He currently chairs the European Primary Care Cardiovascular Society, a WONCA Special Interest Group. He is one of the world's leading academics in primary care, and has developed at Oxford one of the largest and most highly ranked centres for academic primary care globally. He has also made major contributions to growing primary care academic capacity, in terms of people development and research networks. A highly cited primary care clinical scientist, he has authored over 450 peer reviewed publications, has an h-index of 90, with over 63000 citations (36000 since 2013) and 81 papers cited over 100 times, 14 papers cited over 1000 times and 7 papers with over 2000 citations. He has an outstanding track record in cardiovascular research, delivering trials that changed international guidelines and practice, especially in the areas of stroke prevention in atrial fibrillation (BAFTA, SAFE, and SMART trials), heart failure burden and diagnosis (ECHOES and REFER trials), and hypertension self-management (TASMINH series). He is only the fifth ever recipient of the RCGP Discovery Prize in 2018 (an occasional award made since 1953) and received an inaugural Distinguished Researcher Shine Prize plus Best Presentation Prize at the WONCA World Congress in 2018. He was awarded a CBE for services to medical research in the 2018 New Year's Honours. This talk was held as part of the Big Data Epidemiology course which is part of the Evidence-Based Health Care Programme.
Professor Jeffrey Aronson, Consultant Physician and Clinical Pharmacologist, Department of Primary Care Health Sciences, gives a talk on dose-response curves for the EBHC podcast series.
Professor Sir Muir Gray has worked in public health for 40 years, focusing on disease prevention (particularly helping people to stop smoking) and population ageing. He is a renowned leading Consultant in Public Health in Oxford University Hospital NHS Trust and a professor in the University of Oxford's department of Primary Care Health Sciences. Knighted in 2005 for his services to the NHS, he is known as a public health pioneer. In recent years, Sir Muir has gone on to publish a number of lighthearted books including ‘Sod Seventy! The Guide to Living Well'. He joins me on the podcast to talk about why the word retirement should be banned, ‘Excessive Sitting Syndrome' and what we can do to dramatically reduce our risk of serious illness as we age. He argues why ‘clean, clear knowledge' is so important in the 21st century and how he's helped to ensure it's available via the NHS. Listen here on episode 051 The Retirement Café Podcast.
Professor Jeffrey Aronson, Consultant Physician and Clinical Pharmacologist, Department of Primary Care Health Sciences, gives a talk on dose-response curves for the EBHC podcast series.
In quality improvement, measurement is seen as a key driver of change - how well do you know you're doing, if you can't actually measure it. So, when something changes in the NHS (say a new guideline) how can you tell how quickly that's filtering down to the front line. Ben goldacre, from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, joins us to talk about a new proof of concept published on bmj.com, which uses NHS prescribing data to analyse how change propagated through GP practices. Read the full open access research: https://www.bmj.com/content/367/bmj.l5205 https://openprescribing.net/
This guest lecture draws on nearly thirty years' experience of doing qualitative research in a variety of health settings that contain people, blood, injury, disease, emotions, and technologies. Prof Catherine Pope will describe some of the practical difficulties and everyday challenges of doing ethnography in these environments, and reflect on what it feels like to be an embodied researcher. Catherine Pope is Professor of Medical Sociology, and, from July 2019, will be based at the Nuffield Department of Primary Care Health Sciences, University of Oxford. She has championed the use of qualitative methods in health research, and played a leading role in developing qualitative evidence synthesis. Her research includes studies of NHS urgent and emergency care, evaluations of health service organisation and reconfiguration, and projects about everyday health care work. This talk was held as part of the Qualitative Research Methods course which is part of the Evidence-Based Health Care Programme.
This guest lecture draws on nearly thirty years' experience of doing qualitative research in a variety of health settings that contain people, blood, injury, disease, emotions, and technologies. Prof Catherine Pope will describe some of the practical difficulties and everyday challenges of doing ethnography in these environments, and reflect on what it feels like to be an embodied researcher. Catherine Pope is Professor of Medical Sociology, and, from July 2019, will be based at the Nuffield Department of Primary Care Health Sciences, University of Oxford. She has championed the use of qualitative methods in health research, and played a leading role in developing qualitative evidence synthesis. Her research includes studies of NHS urgent and emergency care, evaluations of health service organisation and reconfiguration, and projects about everyday health care work. This talk was held as part of the Qualitative Research Methods course which is part of the Evidence-Based Health Care Programme.
Andrea Levy's novel Small Island was published in 2004, dramatised for television in 2009 and now Helen Edmundson's theatrical adaptation has begun a run at the National Theatre. It tells the stories of Hortense, who grows up in Jamaica and moves to England as part of the “Windrush” generation, and Queenie, who escapes life on a Lincolnshire farm to find herself in inner-city London as social and ethnic dynamics shift after the War. Jenni talks the actors playing Hortense and Queenie, Leah Harvey and Aisling Loftus.How do you raise successful people? Esther Wojcicki claims to have done just that. She is the mother of YouTube CEO Susan Wojcicki, 23andMe Co-Founder and CEO Anne Wojcicki, and Fulbright Scholar and Professor of Pediatrics Janet Wojcicki. Esther has written a book including 'simple lessons for radical results' and she shares her strategies with Jenni, explaining her TRICK theory and why she thinks it works equally well whether you are raising children or managing a company.Why has Leeds become the first city in the UK to report a drop in childhood obesity, what's the significance of this for the rest of the UK and what else is being done throughout Europe and the world to tackle the problem? Jenni is joined by Esther Wojcicki, author of How to Raise Successful People, Susan Jebb, Professor of Diet and Population Health at Nuffield Department of Primary Care Health Sciences at the University of Oxford and Franco Sassi, Professor of International Health Policy and Economics at Imperial College, London. In her latest novel, A Thousand Ships, Natalie Haynes tells the story of the Trojan War from an all-female perspective. She joins Jenni to explain why she decided to give a voice to these overlooked women, girls and goddesses and what can be gained by listening to their stories.Presenter: Jenni Murray
Bill Dunn, Oxford University's Professional Development Advisor, talks to Kamal Mahtani from the Nuffield Department of Primary Care Health Sciences about Personal Development Reviews. Bill gives some of his top tips for preparing for the meeting and ensuring it's a positive experience for everyone - from those at the very start of their career to those nearing retirement.
Jamie Hartmann-Boyce is a Senior Researcher in Health Behaviours, based at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Her work focusses on obesity and tobacco control and her particular interests lie in evidence synthes Though the vast majority of people trying to lose weight do so on their own, without support from healthcare professionals or formal weight loss programmes, most research into weight loss focuses on more intensive programmes. We therefore set out to find out more about what people do when trying to lose weight on their own. As part of this work, we conducted three qualitative systematic reviews to explore people's experiences with self-directed weight loss. The first review provides an overview of the cognitive and behavioural strategies used during self-directed weight loss attempts, and the second two reviews delve further into particular weight loss strategies that emerged as part of the overview, namely self-monitoring and reframing. In this talk, I'll cover key findings from each of the three reviews, and also use these reviews to illustrate how qualitative syntheses can be conducted and used to shed light on people's experiences. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-Based Health Care.
Jamie Hartmann-Boyce is a Senior Researcher in Health Behaviours, based at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Her work focusses on obesity and tobacco control and her particular interests lie in evidence synthes Though the vast majority of people trying to lose weight do so on their own, without support from healthcare professionals or formal weight loss programmes, most research into weight loss focuses on more intensive programmes. We therefore set out to find out more about what people do when trying to lose weight on their own. As part of this work, we conducted three qualitative systematic reviews to explore people's experiences with self-directed weight loss. The first review provides an overview of the cognitive and behavioural strategies used during self-directed weight loss attempts, and the second two reviews delve further into particular weight loss strategies that emerged as part of the overview, namely self-monitoring and reframing. In this talk, I'll cover key findings from each of the three reviews, and also use these reviews to illustrate how qualitative syntheses can be conducted and used to shed light on people's experiences. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-Based Health Care.
The Cochrane Tobacco Addiction Group has produced dozens of reviews of the effects of a wide variety of interventions to help smokers quit. The reviews are updated periodically to incorporate new evidence and the second update of the review focusing on interventions for young people was published in November 2017. Lead author, Tom Fanshawe from the Nuffield Department of Primary Care Health Sciences in the University of Oxford in the UK bring us up to date with the findings.
The Cochrane Tobacco Addiction Group has produced dozens of reviews of the effects of a wide variety of interventions to help smokers quit. The reviews are updated periodically to incorporate new evidence and the second update of the review focusing on interventions for young people was published in November 2017. Lead author, Tom Fanshawe from the Nuffield Department of Primary Care Health Sciences in the University of Oxford in the UK bring us up to date with the findings.
A light hearted account of being treated by the 'wrong' guideline - with a serious conclusion about making sure this doesn't happen. Professor Trish Greenhalgh is a Professor of Primary Care Health Sciences and the Nuffield Department of Primary Care Health Sciences. Trish Greenhalgh is an internationally recognised academic in primary health care and trained as a GP. She joined the Nuffield Department of Primary Care Health Sciences in January 2015 after previously holding professorships at University College London and Queen Mary University of London.
A light hearted account of being treated by the 'wrong' guideline - with a serious conclusion about making sure this doesn’t happen. Professor Trish Greenhalgh is a Professor of Primary Care Health Sciences and the Nuffield Department of Primary Care Health Sciences. Trish Greenhalgh is an internationally recognised academic in primary health care and trained as a GP. She joined the Nuffield Department of Primary Care Health Sciences in January 2015 after previously holding professorships at University College London and Queen Mary University of London.
A podcast about a song about vaping based on the latest evidence from research from Dr Jamie Hartmann-Boyce at the University of Oxford Vaping has exploded onto the scene as an new technology for smoking. Whilst there's a huge amount of debate about vaping in general there is one thing we know: for those already smoking, switching to vaping is much better for you. This interview explores the research behind how we know this, and features the song, 'The Great Vape Debate'. The song was written by Jonny Berliner in collaboration with Dr Jamie Hartmann-Boyce who works in the Cochrane Tobacco Addiction Group in the Nuffield Department of Primary Care Health Sciences at the University of Oxford. You can explore the research at http://www.cochranelibrary.com/ and on Twitter @CochraneTAG. views stated and expressed in this song are entirely personal, and do not represent any official views or opinions of Cochrane.
Professor Paul Aveyard, Nuffield Department of Primary Care Health Sciences gives a talk on behavioural change in evidence based medicine. In our society, we tend to view motivation, the state of 'wanting it' as a prime mover of behaviour. However, research calls this into question both directly and by showing that, even among people with lukewarm motivation, we can enable behaviour change. Using randomised data mainly from randomised trials and other research, we will examine what these forces are and show how they can be harnessed to change behaviour, even when people have seemingly strong preferences.
Professor Paul Aveyard, Nuffield Department of Primary Care Health Sciences gives a talk on behavioural change in evidence based medicine. In our society, we tend to view motivation, the state of 'wanting it' as a prime mover of behaviour. However, research calls this into question both directly and by showing that, even among people with lukewarm motivation, we can enable behaviour change. Using randomised data mainly from randomised trials and other research, we will examine what these forces are and show how they can be harnessed to change behaviour, even when people have seemingly strong preferences.
Dr John MacArtney gives a talk for the Evidence Based Healthcare seminar series. Qualitative researchers employ a range of different approaches to conducting qualitative analyses. In the process, they describe and interpret data, explaining the relationships between the patterns they find and interrogating their findings in various ways to provide thick descriptions of phenomena or explanatory theories. Drawing on his own qualitative analyses on experiences of cancer, Dr John MacArtney will explore some of the ways in which qualitative analysts approach these processes. This lecture will provide the opportunity to demystify an often intangible process and tackle some of the challenges facing qualitative health researchers today. Dr MacArtney is a Senior Researcher with the Nuffield Department of Primary Care Health Sciences at the University of Oxford and is a sociologist of health and illness with specific interests in the diagnosis of cancer, end of life and palliative care, and bereavement. He specialises in qualitative research. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-based Health Care.
Dr John MacArtney gives a talk for the Evidence Based Healthcare seminar series. Qualitative researchers employ a range of different approaches to conducting qualitative analyses. In the process, they describe and interpret data, explaining the relationships between the patterns they find and interrogating their findings in various ways to provide thick descriptions of phenomena or explanatory theories. Drawing on his own qualitative analyses on experiences of cancer, Dr John MacArtney will explore some of the ways in which qualitative analysts approach these processes. This lecture will provide the opportunity to demystify an often intangible process and tackle some of the challenges facing qualitative health researchers today. Dr MacArtney is a Senior Researcher with the Nuffield Department of Primary Care Health Sciences at the University of Oxford and is a sociologist of health and illness with specific interests in the diagnosis of cancer, end of life and palliative care, and bereavement. He specialises in qualitative research. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-based Health Care.
A song about vaping based on the latest evidence from research, from Dr Jamie Hartmann-Boyce at the University of Oxford Vaping has exploded onto the scene as an new technology for smoking. Whilst there's a huge amount of debate about vaping in general there is one thing we know: for those already smoking, switching to vaping is much better for you. This song explore the research behind how we know this. The song was written by Jonny Berliner in collaboration with Dr Jamie Hartmann-Boyce who works in the Cochrane Tobacco Addiction Group in the Nuffield Department of Primary Care Health Sciences at the University of Oxford. You can explore the research at http://www.cochranelibrary.com/ and on Twitter @CochraneTAG. views stated and expressed in this song are entirely personal, and do not represent any official views or opinions of Cochrane.
Dr. Kamal R. Mahtani, Deputy Director of the Centre for Evidence-Based Medicine, in conversation with Professor Richard Hobbs, Head of Nuffield Department of Primary Care Health Sciences, University of Oxford. Dr. Kamal R. Mahtani, Deputy Director of the Centre for Evidence-Based Medicine, in conversation with Professor Richard Hobbs, Head of Nuffield Department of Primary Care Health Sciences, Director of NIHR Collaboration for Leadership in Applied Health Research and Care, and National Director of NIHR School for Primary Care Research. Trust the Evidence is a new podcast series presenting conversations with individuals interested in improving healthcare through the use of better evidence. Send us your thoughts and feedback: cebm@phc.ox.ac.uk. Edited and produced by Alice Rollinson.
Professor Carl Heneghan, Director of the Centre for Evidence-Based Medicine, in conversation with Dr. Jeffrey Aronson, President Emeritus and Honorary Fellow, British Pharmacological Society, and Consultant Physician. Professor Carl Heneghan, Director of the Centre for Evidence-Based Medicine, in conversation with Dr. Jeffrey Aronson, President Emeritus and Honorary Fellow, British Pharmacological Society, and Consultant Physician, Nuffield Department of Primary Care Health Sciences, University of Oxford. Trust the Evidence is a new podcast series presenting conversations with individuals interested in improving healthcare through the use of better evidence. Send us your thoughts and feedback: cebm@phc.ox.ac.uk. You can also listen to previous episodes here. Edited and produced by Alice Rollinson.
Overdiagnosis is the diagnosis of "disease" that will never cause symptoms or death during a patient's lifetime. Newer, more accurate technologies, and the desire to detect disease even earlier means Overdiagnosis is on the rise. Understanding the impact of Overdiagnosis, how to detect it and what to do about it might stem its inexplicable rise and prevent the epidemic of unnecessary testing. Professor Carl Heneghan is a board member of the Preventing Overdiagnosis conference and has an active interest in diagnostic reasoning and how this can, or in some cases cannot, make a real difference to patient outcomes. He is also Professor of Evidence-Based Medicine at the Department of Primary Care Health Sciences at the University of Oxford, Director of the Centre for Evidence-Based Medicine, a fellow of Kellogg College and an NHS Honorary Clinical Consultant and GP.
Overdiagnosis is the diagnosis of "disease" that will never cause symptoms or death during a patient's lifetime. Newer, more accurate technologies, and the desire to detect disease even earlier means Overdiagnosis is on the rise. Understanding the impact of Overdiagnosis, how to detect it and what to do about it might stem its inexplicable rise and prevent the epidemic of unnecessary testing. Professor Carl Heneghan is a board member of the Preventing Overdiagnosis conference and has an active interest in diagnostic reasoning and how this can, or in some cases cannot, make a real difference to patient outcomes. He is also Professor of Evidence-Based Medicine at the Department of Primary Care Health Sciences at the University of Oxford, Director of the Centre for Evidence-Based Medicine, a fellow of Kellogg College and an NHS Honorary Clinical Consultant and GP.
What is Hope? This seminar explored what hope is and invited us to consider what hope means to people in different circumstances. We were delighted to welcome as speakers Peter Hinton (DPhil student at the Department for Continuing Education), Dr Christine Jackson (Associate Professor in History at the Department for Continuing Education), and Prof Carl Heneghan (Professor of Evidence-Based Medicine at the Nuffield Department of Primary Care Health Sciences) who led a multidisciplinary discussion on the theme of 'Hope', particularly as it relates to their own work.
Professor Trish Greenhalgh gives a talk for the Centre for Evidence Based Medicine. Trish Greenhalgh is Professor of Primary Care Health Sciences and Fellow of Green Templeton College at the University of Oxford. She studied Medical, Social and Political Sciences at Cambridge and Clinical Medicine at Oxford before training as an academic GP.
Professor Trish Greenhalgh gives a talk for the Centre for Evidence Based Medicine. Trish Greenhalgh is Professor of Primary Care Health Sciences and Fellow of Green Templeton College at the University of Oxford. She studied Medical, Social and Political Sciences at Cambridge and Clinical Medicine at Oxford before training as an academic GP.
Dr Helen Ashdown is a GP and Clinical Researcher in the Nuffield Department of Primary Care Health Sciences, University of Oxford. During her clinical academic training, she designed and led a study to investigate whether pain on going over speed bumps when travelling to hospital is a good diagnostic test for appendicitis. This was published in the 2012 Christmas edition of the British Medical Journal. She will describe her own bumpy journey through the process of answering a clinical question - navigating the tortuous course from research question, ethics, study design and recruitment through to Christmas radio shows.
Dr Helen Ashdown is a GP and Clinical Researcher in the Nuffield Department of Primary Care Health Sciences, University of Oxford. During her clinical academic training, she designed and led a study to investigate whether pain on going over speed bumps when travelling to hospital is a good diagnostic test for appendicitis. This was published in the 2012 Christmas edition of the British Medical Journal. She will describe her own bumpy journey through the process of answering a clinical question - navigating the tortuous course from research question, ethics, study design and recruitment through to Christmas radio shows.
Schemes which reduce emergency admissions sound like a good thing, but Martin Rowland, professor of health services research, Cambridge Centre for Health Services Research, University of Cambridge, explains how they can go off track. And Mabel Chew gets some advice on the prognosis of children with acute coughs from Matthew Thompson, a senior clinical scientist in the Department of Primary Care Health Sciences, Oxford University.
© 2020-2025 Ivy Podcast Discovery LLC
